Cilostazol Eluting Stent System (CES-1)

cilostazol · JIMRO Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cilostazol Eluting Stent System (CES-1), covering 2025-03-14 to 2025-03-14. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial of Cilostazol Eluting Stent System (CES-1) in De Novo Coronary Artery Lesions [NA]